IL1RL2 and psoriasis: This was due to a significant repression of psoriasis-associated cytokine and chemokine expression in the previously affected lesional skin of anti-IL36R-treated animals, compared to IgG-treated control animals (Figure 6F), and to non-lesional skin samples of the same, anti-IL36R-treated mice (Supplementary Figure 4A).